TREATMENT OF T-CELL LYMPHOMA Russian patent published in 2025 - IPC A61K39/395 A61K31/282 A61K31/7068 G01N33/53 A61P35/02 

Abstract RU 2835929 C2

FIELD: medicine.

SUBSTANCE: invention relates to oncology and can be used in treating T-cell lymphomas expressing KIR3DL2. What is presented is using an antibody which binds the KIR3DL2 polypeptide in a combination with gemcitabine and oxaliplatin for treating T-cell lymphoma (TCL) expressing KIR3DL2. Antibody contains a VH domain with the sequence SEQ ID NO: 49 and VL domain with sequence SEQ ID NO: 44. Also disclosed is a kit containing a pharmaceutical composition containing an anti-KIR3DL2 antibody, a pharmaceutical composition containing oxaliplatin, and a pharmaceutical composition containing gemcitabine.

EFFECT: inventions provide effective treatment of peripheral TCL, adult T-cell leukaemia, TCL associated with enteropathy, or anaplastic large cell lymphoma.

11 cl, 3 dwg, 2 tbl, 3 ex

Similar patents RU2835929C2

Title Year Author Number
COMBINATION THERAPY USING ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER TREATMENT 2014
  • Sahin, Ugur
  • Tureci, Ozlem
  • Mitnacht-Kraus, Rita
  • Woell, Stefan
  • Jacobs, Stefan
  • Khajnts, Kornelia
RU2792932C2
MODIFIED CONSTANT REGION OF ANTIBODY 2023
  • Igava Tomoyuki
  • Siraiva Khirotake
RU2837820C2
ANTI-PCSK9 ANTIBODY AND ITS APPLICATION 2016
  • Wu Hai
  • Chen Bo
  • Feng Hui
  • Yao Sheng
  • Yao Jian
  • Liu Hongchuan
  • Zhang Libo
  • Zhang Jing
  • Meng Dan
RU2756012C2
ANTIBODY AGAINST CD147 2018
  • Fukuchi, Keisuke
  • Nanai, Kayoko
  • Amano, Masato
  • Yoneda, Kozo
  • Totoki, Yusuke
  • Yamamoto, Shoji
RU2785293C2
MOLECULES TARGETING A TYPE III SECRETION SYSTEM 2016
  • Khollands, Endryu
  • Timmer, Dzhon K.
  • Devero, Kuinn
  • Ekelman, Brendan P.
RU2759949C2
BISPECIFIC ANTIBODY 2021
  • Shiku, Hiroshi
  • Akahori, Yasushi
  • Tanaka, Kento
  • Yatsu, Ayaka
  • Ichikawa, Junya
  • Ohtsuka, Toshiaki
  • Kozuma, Shiho
  • Hashimoto, Ryuji
  • Nakayama, Makiko
  • Shinozaki, Naoya
  • Nakamura, Kensuke
  • Watanabe, Ichiro
  • Furuzono, Shinji
RU2840407C1
FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE 2019
  • Kertis, Majkl Stiven
  • Storek, Majkl
  • Vajolett, Sheliya Mari
  • Kalled, Syuzan L.
  • Fakhnou, Kelli S.
  • Khuan, Chen Zhan
  • Stark, Ellen Garber
  • Tejlor, Frederik Robbins
  • Karavella, Dzhastin Endryu
  • Kholers, Vernon Majkl
RU2824402C2
MODIFIED ANTIBODY CONSTANT REGION 2021
  • Igava Tomoyuki
  • Siraiva Khirotke
RU2797273C2
METHODS OF COMBINED TREATMENT OF MALIGNANT NEOPLASMS, INCLUDING AGENTS BLOCKING CTLA-4 AND PD-1 2020
  • Lafejs, Drejk
  • Punnonen, Yukha
  • Bauman, Edvard
  • Bosh, Devid
  • Chekerian, Alissa
  • Grejn, Dzheffri
  • Mauze, Smita
  • Savant, Anandi
  • Annamalai, Lakshmanan
RU2833523C2
IMPROVED ANTI-FLT3 ANTIGEN-BINDING PROTEINS 2019
  • Jung, Gundram
  • Salih, Helmut
  • Vogt, Fabian
  • Zekri-Metref, Latifa
  • Pflugler, Martin
  • Ehnes, Isabelle
RU2830982C2

RU 2 835 929 C2

Authors

Abdelazim, Khatem

Paturel, Karin

Dates

2025-03-06Published

2020-01-20Filed